BRCA2 and neoplasm: Although the SPN and DT showed neither LOH nor any somatic mutation in the second BRCA2 allele and thus cannot be considered as BRCA-dependent tumors, this study highlights the important role and the new opportunities derived from tumor molecular profiling.